Epigenomics Sequencing, Profiling & Analysis Services
Support complex epigenomics studies from assay selection to data interpretation across DNA and RNA modifications, cfDNA, chromatin regulation, and 3D genome organization.

Support complex epigenomics studies from assay selection to data interpretation across DNA and RNA modifications, cfDNA, chromatin regulation, and 3D genome organization.

Our epigenomics services have supported client studies published in Nature Communications, Nature Cancer, Science Advances, and other peer-reviewed journals.



Support epigenomics research across diverse sample types, biological systems, and study areas with flexible workflows tailored to your project needs.

Explore age-associated DNA methylation patterns with epigenetic clock analysis for aging, development, intervention, and comparative research.

Researchers from universities, research institutes, government agencies, and biotechnology organizations worldwide have used our services to support their research.











Explore epigenomics sequencing, profiling, and analysis approaches based on your biological question, from DNA methylation and RNA modification to chromatin regulation, molecular interactions, 3D genome organization, and integrated analysis.
Profile DNA methylation and related modifications using genome-wide, targeted, low-input, and cfDNA methylation sequencing and profiling approaches.
Investigate RNA methylation, other RNA modifications, and epitranscriptomic regulation across coding and non-coding RNA.
Characterize chromatin accessibility, histone modifications, and transcription factor binding.
Study interactions among RNA, proteins, DNA, and chromatin to investigate regulatory relationships.
Map chromatin contacts and genome architecture for 3D genome analysis, from genome-wide interactions to selected regulatory regions.
Integrate complementary molecular layers with epigenomic data analysis and custom bioinformatics to generate interpretable biological evidence.
Focused capabilities for methylation, chromatin, RNA modification, and transcription factor research.
Achieve whole-genome, single-base resolution 5mC profiling with >99% bisulfite conversion efficiency, well suited for comprehensive methylome discovery and DMR analysis.
Profile 935,000+ CpG sites with a standardized array workflow for cohort, disease, tumor epigenetics, and FFPE studies.
Study A/B compartments, TADs, and chromatin loops for 3D genome and long-range regulatory research.
A well-established approach for genome-wide profiling of transcription factor binding and histone marks, ideal for identifying regulatory elements and investigating gene regulation, chromatin states, and disease-associated epigenetic changes.
Generate transcriptome-wide m6A enrichment profiles for broad RNA modification screening and multi-condition comparison.
Map transcription factor binding without a TF-specific antibody, ideal for plants, crops, and non-model organisms.
CD Genomics provides integrated epigenomics solutions for a broad range of research applications, from biological aging and biomarker discovery to disease mechanisms and therapeutic target research. Our support spans study design, epigenomic profiling, sequencing, bioinformatics, and customized analysis strategies tailored to each research question.

Estimate biological age and age-acceleration metrics from DNA methylation data using established or customized epigenetic clock models.
Explore Epigenetic Clock Analysis
Identify and prioritize candidate biomarkers by integrating DNA methylation, hydroxymethylation, chromatin, and regulatory evidence.
Explore Cancer Biomarker Discovery
Integrate epigenomic and expression evidence to identify disease-associated regulatory mechanisms and prioritize potential therapeutic targets.
Explore Drug Target DiscoveryOur workflows combine sequencing, microarray, and mass spectrometry platforms to support diverse epigenomic research needs.

High-throughput sequencing for DNA methylation, chromatin profiling, RNA modification, and 3D genome studies.

Investigate native DNA and RNA modifications, long-range molecular features, and complex genomic regions.

Support standardized methylation profiling and targeted enrichment for focused studies and large research cohorts.

Quantitative mass spectrometry workflows for DNA, RNA, histone, and protein modification analysis.
CD Genomics supports epigenomics projects from study design and method selection through experimental analysis, quality control, bioinformatics, and data delivery. Our broad capabilities allow project strategies to be shaped around the biological question, study design, and analytical objectives.
DNA methylation · RNA modification · Chromatin · 3D genome · Molecular interactions
Tissue · Cells · Blood · Plasma & cfDNA · FFPE · Genomic DNA · RNA
NGS · Long-read sequencing · Microarray · Targeted profiling · LC–MS/MS
Single-assay analysis · Multi-layer integration · Custom analytical strategies
We evaluate suitable approaches before project launch based on resolution, genomic coverage, input requirements, cohort size, and the biological comparison. The goal is to select an assay that fits the question, not simply the most comprehensive method.
Experimental design is reviewed before samples enter the workflow, with attention to biological replicates, assay-appropriate controls, comparison groups, and batch structure to reduce avoidable confounding.
Sample condition, assay compatibility, required output, and downstream analysis needs are reviewed before experimental work begins. Potential limitations can be identified early, before significant project resources are committed.
QC is adapted to the selected assay rather than applied as a generic sequencing checklist. Relevant checkpoints may include library performance, sequencing quality, mapping, enrichment or conversion performance, and signal quality.
The analytical plan follows the biological comparison defined during study design. Contrasts, genomic regions, differential signals, and candidate features are organized around the research question rather than a generic collection of plots.
Results are organized into processed data, key figures, tables, and project reports linked to the original study objective. Important findings, limitations, and candidates for targeted validation or follow-up experiments can be clearly identified.
Selected peer-reviewed studies highlight how our epigenomics services have supported diverse research questions across DNA methylation, chromatin regulation, RNA modification, aging, cancer biology, and related areas.

Whole-genome DNA methylation profiling supported comparative investigation of trophoblast biology in human and marmoset stem cell models.



Stay current with newly available methods, project-planning resources, and activity from CD Genomics Epigenetics.
Map high-confidence candidate m6A sites across the transcriptome at single-nucleotide resolution without antibody enrichment. Qualified projects can start from as little as 10 ng total RNA, making m6A-Atlas well suited to precious or limited samples and studies requiring precise site-level information.
Explore m6A-Atlas
See how DNA methylation, chromatin accessibility, protein–DNA binding, and gene expression can be combined into a stronger evidence chain for mechanism-focused epigenomics research.
Read Article
CD Genomics joined researchers from the international epigenetics community in Baton Rouge to exchange ideas on RNA modification, epigenetic inheritance, DNA methylation, and emerging sequencing technologies.
Researchers from numerous laboratories engaged with our team about ongoing and planned studies. Several discussed project-specific sample and study-design challenges and expressed interest in working with CD Genomics on future epigenomics projects.

Tell us about your research needs. Our team can help evaluate suitable approaches and support your project from study design to data delivery.
Sample type & number · Organism & study groups · Research goal or service · Analysis needs or timeline
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.